4//SEC Filing
Moriarty John B 4
Accession 0001209191-20-059523
CIK 0001750284other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 6:57 PM ET
Size
8.0 KB
Accession
0001209191-20-059523
Insider Transaction Report
Form 4
Moriarty John B
EVP, Ch. Legal Officer & Sec.
Transactions
- Award
Stock Option (Right to Buy)
2020-11-18+161,406→ 161,406 totalExercise: $19.00Exp: 2030-11-17→ Common Stock (161,406 underlying) - Award
Stock Option (Right to Buy)
2020-09-19+252,060→ 252,060 totalExercise: $4.82Exp: 2030-09-18→ Common Stock (252,060 underlying)
Footnotes (2)
- [F1]25% of the shares subject to the option vest on September 8, 2021 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date. The stock option is early exercisable.
- [F2]25% of the shares subject to the option vest on November 18, 2021 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.
Documents
Issuer
Olema Pharmaceuticals, Inc.
CIK 0001750284
Entity typeother
Related Parties
1- filerCIK 0001564621
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 6:57 PM ET
- Size
- 8.0 KB